NEOGEN

Neogen Chemicals Share Price

₹1,714.15 -11.3 (-0.65%)

22 Feb, 2025 21:40

SIP TrendupStart SIP in NEOGEN

Start SIP

Performance

  • Low
  • ₹1,692
  • High
  • ₹1,765
  • 52 Week Low
  • ₹1,176
  • 52 Week High
  • ₹2,420
  • Open Price₹1,730
  • Previous Close₹1,725
  • Volume26,158

Investment Returns

  • Over 1 Month -13.94%
  • Over 3 Month -11.38%
  • Over 6 Month + 8.38%
  • Over 1 Year + 30.75%
SIP Lightning

Smart Investing Starts Here Start SIP with Neogen Chemicals for Steady Growth!

Invest Now

Neogen Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 91.6
  • PEG Ratio
  • 1.9
  • Market Cap Cr
  • 4,522
  • P/B Ratio
  • 5.8
  • Average True Range
  • 103.65
  • EPS
  • 18.71
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -42.88
  • RSI
  • 35.31
  • MFI
  • 29.45

Neogen Chemicals Financials

Neogen Chemicals Technicals

EMA & SMA

Current Price
₹1,714.15
-11.3 (-0.65%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹1,889.12
  • 50 Day
  • ₹1,965.02
  • 100 Day
  • ₹1,961.54
  • 200 Day
  • ₹1,864.62

Resistance and Support

1723.65 Pivot Speed
  • R3 1,827.95
  • R2 1,796.35
  • R1 1,755.25
  • S1 1,682.55
  • S2 1,650.95
  • S3 1,609.85

What's your outlook on Neogen Chemicals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Neogen Chemicals is a leading manufacturer of specialty chemicals in India, specializing in bromine and lithium-based compounds. It supplies over 200 products to pharmaceutical, agrochemical, and engineering industries, with operations spanning domestic and international markets.

Neogen Chemicals has an operating revenue of Rs. 774.39 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 8% is okay, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 28% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Neogen Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-01 Quarterly Results
2024-11-12 Quarterly Results
2024-08-07 Quarterly Results
2024-04-30 Audited Results & Final Dividend
2024-02-09 Quarterly Results

Neogen Chemicals F&O

Neogen Chemicals Shareholding Pattern

51.23%
20.01%
1.6%
7.73%
0%
13.22%
6.21%

About Neogen Chemicals

  • NSE Symbol
  • NEOGEN
  • BSE Symbol
  • 542665
  • Chairman & Managing Director
  • Mr. Haridas Kanani
  • ISIN
  • INE136S01016

Similar Stocks to Neogen Chemicals

Neogen Chemicals FAQs

Neogen Chemicals share price is ₹1,714 As on 22 February, 2025 | 21:26

The Market Cap of Neogen Chemicals is ₹4522.2 Cr As on 22 February, 2025 | 21:26

The P/E ratio of Neogen Chemicals is 91.6 As on 22 February, 2025 | 21:26

The PB ratio of Neogen Chemicals is 5.8 As on 22 February, 2025 | 21:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23